Are We There Yet: The Road to Clinical Development in Women’s Health
June 24, 2026
26AB
Type: Breakout Session
Focus Area:
Patient Advocacy
Venture capital funding specifically for women’s health biotech and pharmaceuticals has undergone a significant transformation since 2023. While the broader "Women's Health" category is often dominated by "Femtech" (apps, digital platforms, and medical devices), the women’s health biopharma sub-sector is seeing results and advancing assets into the clinic. Join this session to hear about exciting developments in women’s health therapeutics, new partnership models and challenges developers face when researching some of the toughest challenges in women’s health.
Moderator
.jpg)
Chief Patient Advocate and Head, Patient Advocacy Center of Excellence
Biotechnology Innovation Organization (BIO)
Speakers
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}